Author Interviews, CDC, Cost of Health Care, Hepatitis - Liver Disease / 05.10.2022
Hepatitis C: Few Insured Persons Receive Timely Treatment, and Disparities Exist
MedicalResearch.com Interview with:
William W. Thompson, Ph.D.
Epidemiologist Division of Viral Hepatitis
CDC
MedicalResearch.com: What is the background for this study?
Response: Prior to this analysis, we knew only an estimated 1.2 million persons initiated hepatitis C treatment with DAA agents in the United States during 2014–2020, far below the number needed to achieve national hepatitis C elimination goals. Further, the number of persons treated was highest in 2015 and declined to its lowest level in 2020.
This analysis used a large national health care claims database to assess the level and timing of hepatitis C treatment among persons with diagnosed HCV infection with breakdowns by sex, age, race, insurance type (i.e., private, Medicaid, and Medicare), and by state.
(more…)